A novel clinical multidimensional transcriptome signature predicts prognosis in bladder cancer.
In conclusion, the multidimensional PCG‑lncRNA‑microRNA signature can be a novel prognostic marker to predict the survival of bladder cancer patients.
PMID: 30226624 [PubMed - as supplied by publisher]
Source: Oncology Reports - Category: Cancer & Oncology Tags: Oncol Rep Source Type: research
More News: Bladder Cancer | Cancer | Cancer & Oncology | Carcinoma | Databases & Libraries | Genetics | Study | Training | Universities & Medical Training